Activation of neutrophils is an important mechanism in pathology of granulomatosis with polyangiitis (GPA). In this study, we evaluated if extracellular vesicles (EV) circulating in plasma of GPA patients could contribute to this process.
Introduction
Granulomatosis with polyangiitis (GPA) is an infrequent, autoimmune disease with still unknown etiology. Several hypotheses suggest that genetic factors like polymorphisms of proteinase inhibitor (alpha-1 antitrypsin), cytokine genes variants (IL-10) or some HLA genotypes might be associated with GPA (1, 2) . According to Chapel Hill Consensus Conference (CHC) among primary systemic vasculitides, GPA is an anti-neutrophil cytoplasmic antibody (with specificity for proteinase 3 -PR3-ANCA or cANCA) associated vasculitis affecting small vessels. This definition implies presence of circulating cANCA and absence or paucity of immune complex deposits in areas of vasculitis by immunohistochemical studies of tissue specimen (3) . Among spectrum of cells participating in pathophysiology of GPA, neutrophils are playing the most important role. The current paradigm of GPA assumes neutrophil activation by IgG anti-PR3 (cANCA), which requires direct recognition of PR3 via Fab region of the antibody, and interaction of the Fc part of the antibody with FcγRs on the neutrophil surface (4, 5) . This causes neutrophil activation, degranulation, generation of reactive oxygen species and eventually trans-migration through the endothelial cell layer (6) (7) (8) . However, a novel mechanisms of immune cells activation in pathophysiology of autoimmune disease like GPA can be linked to extracellular vesicles (EV).
Extracellular vesicles are a heterogeneous population of extracellular particles bounded by a phospholipid bilayer. They are released by practically all types of cells and can be detected in various biological fluids. According to the current nomenclature extracellular vesicles are divided into main groups of exosomes and microparticles (9) . Exosomes are small (50-150 nm) and are derived from endocytic compartment. Microparticles are larger (100-1000 nm) and produced by budding of the plasma membrane following a loss of asymmetric distribution of phospholipids and reorganization of the cytoskeleton (10) . Because distinction between these two population of EV is difficult, classification of EV into exosomes or microparticles is rather dogmatic. Some studies are showing that proteins like CD63, CD81 or CD9 are mostly present in exosomes likely reflecting their origin (11) , whereas these markers can also be detected on larger EV (12) . It is now recognized that EV are an integral part of the intercellular microenvironment and may act as regulators of cell-to-cell communication (10) . Extracellular vesicles can deliver proteins to the target cells or may participate in transferring receptors between cells. Recently, we observed that tumor-derived EV can induce monocytes/macrophage differentiation (13) . It is interesting that EV content may differ from the parent cells, moreover different stimuli may cause release of EV with different cargo (14, 15) . Extracellular vesicles can also contain DNA (including mitochondrial DNA), messenger RNA and microRNA but still it is little known about EV lipidomics. Several studies on extracellular vesicles lipids showed that EV can contain active enzymes linked to lipid metabolism like 12-lipoxygenase, phospholipase A2, C and D or lipid mediators like leukotrienes (16) (17) (18) (19) (20) . The role of extracellular vesicles in GPA and neutrophils activation, especially in the context of lipidomics is still unclear. In this study we analyzed potential of plasma derived extracellular vesicles of GPA patients to activate neutrophils -focusing on oxylipins cargo of EV. We observed that vesicles isolated from GPA patients and not from the healthy controls were able to activate neutrophils and form NETs. These data provide insights into the mechanism by which extracellular vesicles could activate neutrophils and modulate innate immune response under pathological conditions.
Materials and methods

Patients' recruitment and samples collection
We enrolled 10 treatment naïve patients in active stage of GPA and 10 healthy sex and age matched controls. Disease activity was evaluated using Birmingham Vasculitis Activity Score version 3 (BVAS>1). Blood samples were collected in the morning, at least 12h after a meal. Basic laboratory tests (CBC, CRP, anti-PR3 IgG level) were performed in all participants of the study at the time of collection of the peripheral blood. Written informed consent was obtained from all participants of the study and the study protocol was accepted by Jagiellonian University Ethic Committee abiding by the Declaration of Helsinki principles.
Neutrophils isolation
Neutrophils were isolated from healthy donors' peripheral blood collected into tubes Vacutainer (BD Life Sciences, Franklin Lakes, NJ) using Histopaque-1077 gradient centrifugation (Sigma-Aldrich Chemical Co, St Louis, USA ) followed by lysis of remaining erythrocytes with ammonium chloride buffer. Purity (>98%) of the neutrophils fraction was ascertained by flow cytometry and cells viability (>95%) was verified by trypan blue exclusion staining. Immediately after isolation, granulocytes were resuspended in X-VIVO 15 medium (Lonza, Basel, Switzerland).
Extracellular vesicles isolation
Extracellular vesicles (EV) were isolated from the platelet poor plasma of 10 treatment naïve patents with active GPA (BVAS 7-22) and 10 healthy sex and age matched controls by centrifugation. Blood samples were taken into Vacutainer tubes with sodium citrate as anticoagulant. After blood collection, samples were centrifuged for 10 min at 1450g (no brake) to obtain plasma, upper three-fourths of plasma was collected and centrifuged again to obtain platelet poor plasma (PPP, 5000g for 5 min no brake).
PPP was aliquoted and stored in -80°C. Frozen PPP (2.5 mL) was thawed in water bath for 10 min at 25°C and centrifuged for 20 min at 3500g to remove any cryoprecipitate. For EV isolation, collected supernatant was diluted with PBS (7 mL total sample volume) and passed through 0.8 µm syringe filter. Evaluation of EV surface markers was performed by flow cytometry as previously described (21, 22) .
Briefly, EV aliquots (10 µL) were resuspended in PBS, mixed with 5 µL of aldehyde/sulfate-latex beads (4 μm of diameter, Invitrogen, Carlsbad, CA, USA) and incubated at room temperature for 15 min in 1.5 mL Eppendorf tube. After incubation, the content was added with 1 mL of 2% BSA in PBS and incubated overnight with rotation at 4°C. Bead-coupled EV were pelleted by centrifugation at 2700g for 5 min, washed with 1 mL of 2% BSA in PBS and centrifuged again. The pellet was resuspended with 50 μL of PBS and stained with the antibodies anti-CD63 (FITC, BD Biosciences, USA) and anti-CD81 (PerCP-eFluor 710, ThermoFisher Scientific, Waltham, MA, USA) for 30 min at room temperature.
Gating of EV-decorated latex beads was on FCS/SSC parameters, thus unbound EV or antibody aggregates were excluded from the analysis (Supplemental Figure S1 ). 
Visualization of neutrophil extracellular traps formation
Isolated granulocytes were resuspended in X-VIVO 15 medium (2.5x10 
Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.0 software (GraphPad Software Inc, San Diego, CA). All comparisons were done using one-way analysis of variance (ANOVA) with Tukey's post hoc test or t-Student test and Mann-Whitney U test. Descriptive statistics were presented as a mean ± standard deviation or median ± interquartile range. Type I statistical error P<0.05 was considered significant.
Results
The study subjects and extracellular vesicles characteristics All GPA patients were newly diagnosed and treatment naïve, and were anti-PR3 IgG positive. BVAS disease activity score was between 7 and 22 (median = 14). Clinical laboratory tests showed that in comparison with healthy controls, GPA patients had elevated number of polymorphonuclear leukocytes (PMN) and peripheral blood mononuclear cells (PBMC) (Supplemental Table S3 ).
EV isolated from GPA patients (EV-GPA) or healthy controls (EV-HC) were in the same size range and concentration ( Fig. 1 A and B) . Moreover, there were no differences in expression of EV markers. Both EV-GPA and EV-HC expressed CD63 and CD81 (Fig. 1C) . All EV samples were free of IgG anti-PR3 antibodies and bacterial endotoxins.
Extracellular vesicles mediated neutrophils activation
To evaluate whether plasma derived EV can participate in granulocytes activation observed in GPA, we performed experiments in which neutrophils isolated from healthy donors were stimulated with EV.
Using our preparatory technique, EV 10x concentrated because 250 µL of EV in PBS was obtained from 2.5 mL of PPP. To mimic EV abundance in plasma, neutrophils were stimulated with 25 µL of EV diluted 10-fold in the total cell suspension volume. First, neutrophils were stimulated with EV-GPA or EV-HC alone. In result, no differences were noticed between cells stimulated with EV-GPA or EV-HC and negative control of medium. For the next experiments, neutrophils were primed with GM-CSF (25 ng/mL) before addition of EV. Following stimulation with EV, ROS production ( Fig. 2A) and release of dsDNA (Fig. 2B) were observed. These results were present only if EV-GPA were used. Stimulation of primed neutrophils by EV-HC resulted in absence of ROS production or dsDNA release. Moreover, direct microscopy showed that DNA released by intact live neutrophils stimulated with EV-GPA was likely of mitochondrial origin (Fig. 2C) . To analyze how priming can influence EV mediated activation of neutrophils, we compared primed or not primed cells incubated with EV stained by fluorescent tracker (PKH67). Biding or uptake of EV was evaluated by flow cytometry. We observed that percentage of PKH67 positive cells (nautrophils/EV aggregates) was higher for primed cells, however, this was evident only for EV-GPA (PKH 67 positive cells: primed vs. unprimed: P<0.05, Fig. 3 and Supplemental Figure. S5 ).
Targeted oxylipins lipidomics of extracellular vesicles
To identify putative stimuli causing neutrophils activation we performed targeted oxylipins analysis of EV using HPLC-MS/MS. Out of 14 quantified oxylipins, the lowest concentration in EV was observed for LTC 4 (EV-GPA: 16.2±8.5 vs. EV-HC: 16.0±8.2 pg/mL, P>0.05, Supplemental Figure S6 ) and the highest for 13,14-dihydro-15-keto PGE 2 (EV-GPA: 818±448 vs. EV-HC: 819±448 pg/mL, P>0.05, Supplemental Figure S6 ). Significant differences between EV-GPA and EV-HC were present for LTB 4 (EV-GPA: 470±176 vs. EV-HC: 215±107 pg/mL, P<0.05), 5-oxo-ETE (EV-GPA: 524±279 vs. EV-HC: 221±81.2 pg/mL, P<0.05) and 5-HETE (EV-GPA: 62.9±31 vs. EV-HC: 28.9±15.7 pg/mL, P<0.05) (Fig. 4) .
Oxylipins mediated neutrophils activation
To confirm functional importance of the oxylipins more abundant in EV-GPA we stimulated neutrophils for ROS production and dsDNA release with pure chemical LTB 4 and 5-oxo-ETE. 5-HETE, precursor of 5-oxo-ETE, had no activity at the measured concentration (Supplemental Figure S7) . Stimulation of neutrophils with escalated concentrations of LTB 4 or 5-oxo-ETE increased ROS production or release of dsDNA at the minimal concentration of 4 pg/mL. The peak levels of ROS were observed in cells stimulated with 40 pg/mL of LTB 4 or 5-oxo-ETE (Fig. 5A) . The highest levels of dsDNA release occurred after stimulation of granulocytes with 400 pg/mL of LTB 4 or 5-oxo-ETE (Fig. 5B) . However, alike EV-GPA stimulation, neutrophils activation by LTB 4 or 5-oxo-ETE required a prior GM-CSF priming (Fig. 5C ).
Discussion
Circulating EV were already suggested to participate in pathophysiology of autoimmune diseases, including GPA. However, most of the previous studies were limited to the descriptive observations. (30) . Interestingly, formation of neutrophil extracellular traps by activated neutrophils originally was considered one of the neutrophil death pathways, involving the rearrangement of nuclear and granular architecture which proceeded from the dissolution of internal membranes, followed by chromatin decondensation, cytolysis to formation of nuclear DNA fibers traps (31) (32) (33) . However, we reported that neutrophils can form NETs consisting of mitochondrial DNA in a ROS dependent mechanism and remain viable (34, 35) . This observation may shed light on a persistence of innate immune response activation in autoimmune disorders.
Mechanism of activation neutrophils in GPA involves binding of self-reactive anti-PR-3 antibodies, which stimulate these cells (4, 5, 36) . In the present study stimulation with small EV isolated from the plasma of GPA patients led to ROS production and release of dsDNA in GM-CSF primed neutrophils.
The requirement for the neutrophil priming was met by preincubation with GM-CSF prior to stimulation.
Higher levels of priming cytokines like TNF-α and GM-CSF were previously documented in GPA by us and others, and these observations may explain occurrence of priming effects in vivo (37, 38) .
Moreover, we reported in patients with GPA that level of circulating cell free mitochondrial DNA is higher in comparison with healthy controls (39) . Taken together, presented results demonstrate that neutrophil extracellular traps could be an important mechanism of granulocytes activation in pathophysiology of GPA. Since neutrophil is one of the key players in pathophysiology of GPA the current findings expand the knowledge supporting this idea.
Beside increased binding and uptake of EV by primed granulocytes, the cells activation may result from oxylipins cargo of EV. This has been shown before in studies on LTB 4 or 5-oxo-ETE mediated neutrophil aggregation, adherence, calcium mobilization, ROS production or chemotaxis. All these effects required neutrophils priming with GM-CSF or TNF-α (40-44). Our result on LTB 4 and 5-oxo-ETE stimulation are in line with these studies. The novel finding of the current study is that EV stimulation caused release of dsDNA along with ROS production. This was detectable when primed granulocytes were stimulated with LTB 4 or 5-oxo-ETE, moreover, only EV-GPA had these stimulatory properties containing doubled cargo of LTB 4 and 5-oxo-ETE. We also noticed that EV-HC, which concentration of LTB 4 and 5-oxo-ETE was theoretically sufficient for granulocytes activation did not stimulate primed cells to ROS production or dsDNA release. This could be explained by several factors.
First, due to a complexity of EV cargo, EV-HC can contain molecules suppressing neutrophil activation.
Anti-inflammatory potential of EV has been reported for neutrophil-derived microparticles isolated from healthy donors or rheumatoid arthritis patients (48, 49) . Second, EV-HC might be deficient in some target molecules crucial for internalization by granulocytes. Duchez et al. reported that active 12-lipoxygenase was essential for neutrophils internalization of platelet derived EV (45) , while studies of Maugeri et al. showed that this process required presence of HMGB1 which was absent in microparticles isolated from healthy donors (46, 47) . In the current study we did not analyzed any potential proteins involved in EV uptake by granulocytes. However, we observed that priming of neutrophils with GM-CSF resulted with increased EV biding/uptake only for EV-GPA, explaining lack of EV-mediated neutrophils activation when EV-HC were used. However, only experiments using antagonists of receptors BLT1 or 2 and OXER1 could provide additional evidence to confirm the specific role of these two oxylipins.
Mechanism of release and intracellular origin of small EV is difficult to study ex-vivo, thus a cellular source of plasma circulating EV remains uncertain. In contrast to large microparticles, classical lineage membrane markers like CD11b for granulocytes or CD42a for platelets can't be used (50) . However, some previous studies provided information on the origin of EV by their oxylipins content (51, 52). (56) . Interestingly enough, 5-oxo-ETE is the major metabolite of 5-HETE formed during ROS production in neutrophils (57) . We published previously on increased biosynthesis of these two mediators in the asthmatics following positive challenge with a house dust mite allergen, which correlated with the late phase of allergic inflammation (58) . Taken together, it is highly plausible that granulocytes are the main source of small EV in patients with GPA. We acknowledge this study lacked appropriate methods to evaluate ex-vivo the mechanism of EV formation, and this will require future investigations.
In conclusions, we described a novel observation that primed neutrophils can be stimulated by circulating EV-GPA to produce ROS and release dsDNA. Moreover, by a targeted lipidomics we demonstrated that pro-inflammatory oxylipins of 5-lipoxygenase pathway had increased concentration in EV-GPA, and their activity could be mimicked by chemically pure LTB 4 or 5-oxo-ETE. The current results also confirm that release of dsDNA by NET formation is important mechanism of neutrophils activation in pathophysiology of GPA.
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